These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19075276)

  • 21. Repeated topical treatment, in contrast to single oral doses, with Vitamin A-containing preparations does not affect plasma concentrations of retinol, retinyl esters or retinoic acids in female subjects of child-bearing age.
    Nohynek GJ; Meuling WJ; Vaes WH; Lawrence RS; Shapiro S; Schulte S; Steiling W; Bausch J; Gerber E; Sasa H; Nau H
    Toxicol Lett; 2006 May; 163(1):65-76. PubMed ID: 16243460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
    Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
    J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of supplemental β-carotene compared to retinyl palmitate on fatty acid profile and expression of mRNA from genes involved in vitamin A metabolism in beef feedlot cattle.
    Condron KN; Waddell JN; Claeys MC; Lemenager RP; Schoonmaker JP
    Anim Sci J; 2017 Sep; 88(9):1380-1387. PubMed ID: 28370816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy.
    Benner SE; Lippman SM; Wargovich MJ; Lee JJ; Velasco M; Martin JW; Toth BB; Hong WK
    Int J Cancer; 1994 Nov; 59(4):457-9. PubMed ID: 7960211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.
    Lippman SM; Batsakis JG; Toth BB; Weber RS; Lee JJ; Martin JW; Hays GL; Goepfert H; Hong WK
    N Engl J Med; 1993 Jan; 328(1):15-20. PubMed ID: 8416267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET).
    Thornquist MD; Omenn GS; Goodman GE; Grizzle JE; Rosenstock L; Barnhart S; Anderson GL; Hammar S; Balmes J; Cherniack M
    Control Clin Trials; 1993 Aug; 14(4):308-24. PubMed ID: 8365195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
    Omenn GS
    Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
    Papadimitrakopoulou VA; Clayman GL; Shin DM; Myers JN; Gillenwater AM; Goepfert H; El-Naggar AK; Lewin JS; Lippman SM; Hong WK
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1083-9. PubMed ID: 10522499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.
    Lotan R; Xu XC; Lippman SM; Ro JY; Lee JS; Lee JJ; Hong WK
    N Engl J Med; 1995 May; 332(21):1405-10. PubMed ID: 7723796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
    Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
    JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
    Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
    Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot randomized phase II study of celecoxib in oral premalignant lesions.
    Papadimitrakopoulou VA; William WN; Dannenberg AJ; Lippman SM; Lee JJ; Ondrey FG; Peterson DE; Feng L; Atwell A; El-Naggar AK; Nathan CO; Helman JI; Du B; Yueh B; Boyle JO
    Clin Cancer Res; 2008 Apr; 14(7):2095-101. PubMed ID: 18381950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
    Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
    J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteotoxicity after chronic dietary administration of 13-cis-retinoic acid, retinyl palmitate or selenium in mice exposed to tumor initiation and promotion.
    Forsyth KS; Watson RR; Gensler HL
    Life Sci; 1989; 45(22):2149-56. PubMed ID: 2601568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
    Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
    Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of beta-carotene and antioxidant vitamins in the prevention of oral cancer.
    Garewal HS
    Ann N Y Acad Sci; 1992 Sep; 669():260-7; discussion 267-8. PubMed ID: 1444031
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers.
    Liede KE; Alfthan G; Hietanen JH; Haukka JK; Saxen LM; Heinonen OP
    Eur J Clin Nutr; 1998 Dec; 52(12):872-6. PubMed ID: 9881881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.
    Tsao AS; Liu D; Martin J; Tang XM; Lee JJ; El-Naggar AK; Wistuba I; Culotta KS; Mao L; Gillenwater A; Sagesaka YM; Hong WK; Papadimitrakopoulou V
    Cancer Prev Res (Phila); 2009 Nov; 2(11):931-41. PubMed ID: 19892663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.